Filtros de búsqueda

Lista de obras de

A Phase I study of safety, pharmacokinetics, and pharmacodynamics of concurrent everolimus and buparlisib treatment in advanced solid tumors

artículo científico publicado en 2020

Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials

artículo científico publicado en 2019

Afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings

scientific article published on 20 June 2020

FDA Oncology Center of Excellence Project Renewal: Engaging the Oncology Community to Update Product Labeling for Older Oncology Drugs

artículo científico publicado en 2020

Intranasal Ketamine and Its Potential Role in Cancer-Related Pain.

artículo científico publicado en 2018

New and Worsening Long-term Immune-Related Adverse Events with PD-1/PD-L1 Pathway Agents in Patients with Cancer

scientific article published on 10 January 2020

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

scientific article published on 14 August 2020

Rationale, Opportunities, and Reality of Biosimilar Medications

artículo científico publicado en 2018

Reply to African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies

scientific article published on 28 March 2019

Reply to Tumor-associated macrophages: "Good cop-bad cop"

scientific article published on 12 February 2019

Reply to body fat indices and survival in immunotherapy-treated patients with cancer

artículo científico publicado en 2020

Safety of Intranasal Ketamine for Reducing Uncontrolled Cancer-Related Pain: Protocol of a Phase I/II Clinical Trial

scientific article published on 30 April 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda